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Abstract
Background. Hepatic resection for malignancies or symptomatic benign liver lesions remains the standard of treatment.
Historically, the principal cause of mortality during liver resection was intraoperative bleeding. Advances in surgical and
anesthetic techniques, along with application of new technologies, have decreased blood loss and dramatically improved the
outcomes for major liver surgery.
Methods. The purpose of this prospective study was to determine the utility of a saline-cooled radiofrequency coagulation
device (TissueLink Medical, Inc.) for hepatic resection. Intraoperative bleeding, blood transfusion, postoperative bile leak,
and other complications were noted.
Results. The results are described for 170 patients undergoing hepatic resection over a three-year period. There were no
intraoperative or postoperative deaths. Six patients in the series received blood transfusions for a transfusion rate of 3.5%.
Four patients experienced a transient postoperative bile leak. Three of the four closed spontaneously prior to discharge home,
and the fourth closed promptly after ERCP. There were no episodes of postoperative hemorrhage, hepatic failure, liver
abscess, or reoperation.
Conclusions. The saline-cooled radiofrequency coagulation device is very effective in achieving intraoperative hemostasis and
facilitates liver parenchymal transection during hepatic resection.
KeyWords: Blood conservation, colon cancer, HCC, hepatic resection, liver cancer, liver resection, radiofrequency coagulation
Introduction
Hepatic resections for tumors or symptomatic benign
liver lesions have been performed for more than
50 years [1]. Traditionally, the principal cause of
morbidity and mortality in hepatic resection was
directly related to intraoperative bleeding [2–5]. There
are many anatomical challenges that make liver surgery
complex. The liver has a dual blood supply consisting
of the hepatic artery and portal vein, and receives a
significant proportion of cardiac output. Most high
volume medical centers with specialized hepatobiliary
units report median blood loss of 800–1800 ml for
major liver resections, with operative transfusion rates
of 15%–35% [6–11]. Large resection series in cirrhotic
patients indicate even higher blood loss and transfusion
rates [12–14]. Perioperative blood transfusion is a risk
factor for poor outcome after liver resection, and
blood conservation methods should be used to avoid
transfusion [15].
Most of the blood loss during hepatic resection is
encountered during transection of the liver paren-
chyma. With anatomical resection, this blood loss can
be minimized with prior control of the inflow pedicle
and division of ipsilateral hepatic vein. Non-anatomical
resections and division of steatotic or cirrhotic livers
are notoriously difficult due to bleeding from the
parenchyma. A better understanding of hepatic anat-
omy, advances in surgical technique, and refinements
in anesthetic management have dramatically improved
the outcomes of major hepatic resection in the last
decade [16–20]. This has also led to a widespread
acceptance of live donor hepatectomies for liver
transplantation [21–22].
Various methods and techniques have been de-
scribed to divide the liver parenchyma, but none are
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ideal. Desire to minimize blood loss, and ability to
control blood vessels and bile ducts encountered
during parenchymal division, have to be balanced
against lateral damage to remaining tissue and vital
structures. In recent times, further technological
advances have resulted from an explosion in minimally
invasive technology. Many of these innovative instru-
ments have been applied in open surgical procedures to
reduce blood loss. Liver surgeons today have a wide
array of electrosurgical devices, staplers, and hemo-
static agents to choose from for operative hepatic
surgery. In this report, we describe our experience with
170 hepatic resections using a saline-cooled radio-
frequency coagulation device.
Methods
Patient and operative features
One hundred seventy open liver resection procedures
were performed at the University of Pittsburgh Medi-
cal Center/Starzl Transplant Institute from April 2001
to May 2004. Of the series, 55% were male and 45%
female. The mean patient age was 62 years old. The
indications for liver resection are shown in Table I.
Malignancy was the indication for hepatic resection in
121/170 patients (71%), and 49/170 (29%) were for
symptomatic benign liver lesions. The most common
indication for malignancy was resection of colorectal
cancer metastases, followed by resection for HCC.
Cirrhosis was present in 10/170 patients (6%), and all
of these patients were considered Child’s A. The
operative procedures performed are shown in Table II.
Fifty-three percent of the cases consisted of formal
hepatectomies (lobectomy, trisegmentectomy, or left
lateral segmentectomy). An additional wedge resection
of a second tumor was performed in 29 patients.
Open radiofrequency ablation of a liver tumor was
combined with hepatic resection in 46 patients. An
implantable hepatic artery infusion pump was also
placed following resection for colorectal metastases in
16 patients.
Saline-cooled radiofrequency coagulation devices
The saline-cooled radiofrequency-powered devices
(TissueLink Medical, Inc, Dover, NH) utilized are
shown in Figure 1. The original device is the Tissue-
Link Floating Ball (Figure 1A and 1D). The device
plugs into a standard operating room Bovie electro-
surgical generator. The coagulation power is typically
set between 90–100 W. A sterile liter of 0.9% saline is
connected to the irrigation tubing and adjusted for
a drip rate of 4–8 cc/minute. The device conducts
Table I. Indication for hepatic resection
Liver lesion # Patients %
Colon/rectal cancer metastasis 70 41
Hepatocellular carcinoma (HCC) 13 8
Cholangiocarcinoma 8 5
Gallbladder cancer 10 6
Neuroendocrine tumor 4 2
Breast cancer metastasis 6 3
Sarcoma 3 2
Other metastatic cancer 7 4
Adenoma 5 3
Focal nodular hyperplasia (FNH) 7 4
Hemangioma 18 11




Table II. Type of hepatic resection performed
Operative procedure # Cases %
Right hepatic lobectomy 49 29
Left hepatic lobectomy 16 9
Left lateral segmentectomy 20 12
Trisegmentectomy/extended lobectomy 5 3
Partial lobectomy/wedge resection 65 38
Central liver resection 9 5
Caudate lobectomy 1 1
Cystectomy 5 3
Total 170 100
Figure 1. Selection of TissueLink coagulation devices. The device is
a hand-held, saline-cooled radiofrequency-powered electrode that
plugs into a standard electrosurgical generator (A). Shown are
different tip configurations consisting of blunt DS3.0 (B), sharp
DS3.5c (C), Floating Ball (D), and SH Hook (E).
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radiofrequency energy from the generator to the
electrode tip where continuous low-volume saline
irrigation cools the contact interface with the hepatic
tissue, keeping surface temperature 100–105C. This
avoids the eschar and char formation that occurs with
Bovie electrocautery pencil. The thermal energy results
in heat that denatures protein in the vessel wall and
shrinks collagen, thereby sealing blood vessels.
Subsequent design modifications of the Floating Ball
allow for combined dissection and sealing with an
exposed blunt or sharp (cone-head) distal tip
(Figure 1B, DS3.0, and Figure 1C, DS3.5c). Another
modification is the SH Hook (Figure 1E) that can be
used to facilitate laparoscopic liver resection.
Surgical technique
If a formal lobectomy is to be performed, then the
ipsilateral hepatic artery and portal vein branch
are ligated in the hilum. The liver is elevated from the
inferior vena cava, and short hepatic veins are secured,
thereby exposing the juncture of the right and middle/
left hepatic veins with the IVC. The right hepatic vein
(for right lobectomy) or middle/left hepatic veins (for
left lobectomy) are divided with endoGIA vascular
stapler under direct vision [23]. Intraoperative liver
ultrasound is routinely performed to identify extent of
tumor and help delineate the optimal resection plane.
If a non-anatomic partial lobectomy or large wedge
resection is to be performed, then the operation
proceeds directly with the parenchymal transection
phase.
The liver capsule is scored with electrocautery for
a few mm of depth. This is important to prevent gas/
steam build-up under Glisson’s capsule and avoid a
large popping/explosion noise [24]. The liver tissue is
then ‘precoagulated’ by holding constant pressure with
the radiofrequency coagulation device and stroking
along the transection line in a ‘painting manner’. Small
microbubbles of boiling saline are observed and the
liver tissue will actually turn a whitish-yellow color
(rather than black eschar observed with dry cautery).
The device works well at a 60 angle, and can be gently
rotated/swirled within the fingers to avoid adhesion.
The first assistant uses a suction device adjacent to the
contact site along the line of resection. If there is too
much or too little saline, then proper function is
impeded. The depth of thermal coagulation is
proportional to the power setting of the generator and
duration of contact with the liver parenchyma. In
general, a 5 mm depth of thermal coagulation is
obtained. Once adequate coagulation is achieved, the
hepatic parenchyma can be divided with Bovie elec-
trocautery or scissors. If the cone-tipped DS3.5c is
being used, then the liver can actually be divided by
short tension-controlled downward sweeping strokes
of the sharp tip. If bleeding is encountered while
progressing through the resection zone, hemostasis can
be achieved by rolling over this area with the side of the
device.
When crossing blood vessels are encountered, they
are skeletonized by dissection on each side and then
coagulated by gentle, direct contact above and below
the blood vessel for a few seconds. The saline-cooled
radiofrequency coagulation devices function as a ‘wet
electrode’ and can readily seal blood vessels 3–6 mm
in size. Larger vessels are secured with clips, suture
ligatures, or vascular staplers. The TissueLink devices
also work quite well in combination with an ultrasonic
or hydrojet dissector [25]. These dissectors aspirate the
hepatic parenchyma and expose the crossing blood
vessels that can rapidly be coagulated and sealed by the
radiofrequency coagulation devices. In the 170 cases
reported in the current series, approximately one-third
utilized the Floating Ball, one-third the DS3.0, and
one-third the DS3.5c.
Evolution of transection technique
In the last 50 cases of major hepatic resection, our
preferred parenchymal transection technique has
evolved to begin with standard cautery to score the
surface (capsule) of the liver along the plane of division
determined by intraoperative ultrasound. This is
followed by precoagulation and dissection with the
TissueLink sharp (cone head) tip to a depth of 3–4 cm
in the parenchyma or until dominant crossing middle
hepatic vein branches are encountered. Subsequently,
inflow occlusion is achieved with a Potts-looped wide
vessel loop around the hepatoduodenal ligament
secured with a blunt right-angle clamp. The remainder
of the liver parenchymal transection is accomplished
with repetitive application of a crushing endoGIA
vascular stapler (45 mm straight blue cartridge) passed
after tunneling with a large Kelly clamp. Hemostasis of
any oozing parenchyma is then completed with the
TissueLink device. Argon beam coagulator is not used
on the cut edge of the liver. For formal right hemi-
hepatectomy, total inflow occlusion time has ranged
from 4 minutes to 18 minutes (mean 10 minutes) to
complete the lobectomy. Advantage of the combined
TissueLink and staple technique is the rapid speed by
which the entire right lobe parenchymal ‘slice’ can be
performed. Disadvantage is the cost of these staplers,
and at times the transected liver surface may not be as
flat as achieved with other methods, necessitating the
placement of a few figure-of-eight hemostatic sutures.
Results
Post-op morbidity
Hepatic resection was successfully performed in 170
patients over a three-year period. There were no
intraoperative or postoperative deaths in the series.
There were no episodes of postoperative hemorrhage,
liver failure, or reoperation. Postoperative morbidity
included a few patients with ileus requiring transient
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replacement of nasogastric tube. No abdominal or
hepatic abscesses were noted related to the coagulation
zone at the remnant liver edge. One patient who
underwent central liver resection for gallbladder cancer
experienced a pulmonary embolus two weeks post-
operatively and was readmitted for anticoagulation.
Mean and median length of stay was 6.5 and 6.0 days,
respectively.
Blood transfusions
Blood transfusions were given in six patients, for an
overall transfusion rate of 3.5% (6/170). Five patients
received the packed red blood cells (pRBC) in the
operating room, and one patient received 2 units of
pRBC in the recovery room when her postoperative
hematocrit was 17.3%. In those patients requiring
blood transfusion, the number of units of pRBC
transfused ranged from 1–3 units, with a mean of 2.0
units. Average estimated blood loss (EBL) was 100 cc
for the liver parenchymal transection phase. The range
of EBL was 25–500 cc. Since recorded EBL is some-
what subjective and often differs in estimate between
the surgeon, the anesthesiologist, and the circulating
nurse, we also calculated DHct (preoperative hema-
tocrit–nadir postoperative hematocrit) to provide an
objective assessment of changes in blood count. The
DHct reflects actual blood loss as well as hemodilution
by perioperative fluid replacement. The mean DHct for
the 170 patients was 7% (range 0%–24%).
Bile leaks
A closed-suction bulb drain was routinely placed next
to the cut-edge of the liver in*95% of cases to monitor
for postoperative bleeding or bile leak. Patients
undergoing small wedge resections were closed with-
out a drain. Bile leaks were observed in 4/170 patients
for an overall leak rate of 2.3%. In three of the patients,
the bile leak sealed spontaneously on post-operative
days #3, 4, and 4. The fourth patient required an
ERCP that resulted in prompt closure. There were no
reoperations or infections related to the bile leaks. This
low bile leak rate may be attributed in part to the
practice of the surgical team routinely performing
cholecystectomy and completion intraoperative
cholangiogram through the cystic duct stump to assess
for bile leak from the cut edge or divided hepatic duct
stump. Any detected bile leaks were oversewn with
prolene suture.
Discussion
In the current study, saline-cooled radiofrequency
coagulation was used to achieve liver hemostasis in 170
patients undergoing hepatic resection. The technique
consists of precoagulation of liver parenchyma along
the line of resection with a hand-held device that plugs
into a conventional Bovie generator, followed by tissue
division using scissors or Bovie cautery. The newer
generation electrodes have tip configurations that allow
for simultaneous dissection and coagulation. Six
patients in the series received blood transfusions for a
transfusion rate of 3.5%. Four patients experienced a
transient postoperative bile leak, and three of the four
closed spontaneously prior to discharge home. The
devices appear safe as there were no instances of
hepatic failure, postoperative hemorrhage, or liver
abscess. Further, the low rate of blood transfusion is
significantly less than our own previous reports [3–6],
or the 15%–33% transfusion rate reported in most
large hepatic resection series [7–11].
For several years before adopting this technique, the
parenchymal transection was accomplished by passing
a large right angle clamp through the liver tissue that
was secured with crushing ties. It was our experience
that the incidence of post-operative bile leaks, and need
for blood transfusion was greater with this earlier
approach. Since this was not a prospective, random-
ized study, we are cautious in not directly comparing
the results of the two techniques. The cost of the
TissueLink device is approximately $875 per device.
Prior to use of the TissueLink device, a harmonic
scalpel, as well as application of a fibrin glue sealant to
the cut edge of the liver, was often utilized. Although a
formal cost-analysis has not been performed, we
believe the savings in avoiding the use of fibrin glue and
other hemostatic devices balance the cost of the
TissueLink device.
This study is the largest reported series using saline-
cooled radiofrequency coagulation for hepatic resec-
tion. Sturgeon et al. described their early experience
with the Floating Ball device in seven patients under-
going hepatic resection for HCC or colorectal cancer
metastases [26]. There were no blood transfusions,
postoperative bile leaks, or hemorrhages. Sakamoto
et al. recently reported on 16 hepatic resections where
the Floating Ball was used in combination with a
bipolar LigaSure diathermy device [27]. In this study,
there was significantly less blood loss compared to
well-matched historical controls where the liver was
divided with conventional crush clamp method during
inflow occlusion. It has also been reported for use in
liver resection combined with ultrasonic surgical
aspirator [28].
Multiple surgical techniques have been described to
control bleeding during hepatic resection. This
includes extra-hepatic ligation of the hilar structures,
intra-hepatic pedicle ligation along Glisson’s capsule,
Pringle maneuver, half-Pringle maneuver, and total
vascular exclusion [29–34]. The advent of electro-
surgical devices revolutionized surgery, and most
operating rooms worldwide utilize a conventional
Bovie-type electrosurgical generator, especially for
hepatic surgery. The Bovie electrocautery can be used
during hepatic surgery to score the liver capsule and
effectively seal off small blood vessels (1–2 mm).
However, to achieve hemostasis for larger blood vessels
in the liver parenchyma, higher power is required
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resulting in excessive heat. The temperature often
exceeds 350C, causing significant lateral damage,
charring, and eschar formation. Eschar usually sticks
to the electrode and has a tendency to separate from
the liver parenchyma as the electrode is moved.
Charring makes it difficult to distinguish between
parenchyma, vascular, and biliary structures. It is
difficult to divide the liver parenchyma with conven-
tional Bovie electrocautery alone without risking major
blood loss.
The TissueLink devices combine radiofrequency
electrical energy with low irrigation of saline to conduct
energy and provide a cooling effect to the tissue. This is
capable of sealing structures 3–6 mm in diameter
without producing high temperature or excessive
charring and eschar. Structures more than 6 mm in
diameter should be divided in conventional manner
with clips or ties. Constant suction is required to clear
the saline used for irrigation. The first generation
TissueLink device utilized a floating ball tip that
‘precoagulated’ liver tissue which is then divided with
scissors [26] or Bovie cautery. One common criticism
is the slow pace of liver resection with this device. This
was improved with later generation devices consisting
of a blunt or sharp (cone head) tip that allow for
dissection and sealing. These devices can also be used
in combination with ultrasonic dissector or hydrojet to
shorten parenchymal transection time. Properly used,
these devices can result in near ‘bloodless’ liver surgery.
Similar to most new technologies, there is a learning
curve to optimize use of the instrument, and most
surgeons are comfortable after 5–6 procedures.
Recently, application of an internally cooled tip
radiofrequency (RF) probe to precoagulate liver tissue
along the planned transection line has also been
described [35–37]. In these studies, a single RF elec-
trode is inserted sequentially into the liver parenchyma
under ultrasound guidance to achieve a 1-cm zone of
necrosis along the planned resection line. The hepatic
resection is then performed with a scalpel [35–37]. One
disadvantage of this technique compared to the
TissueLink devices is that a specialty generator is
required. Another disadvantage is the need for multiple
insertions of the device deep into the parenchyma,
whereas the TissueLink devices allow for simultaneous
dissection and coagulation under direct vision. Others
have reported on the use of bipolar devices, ultrasonic
shears, and fibrin sealants to help achieve hemostasis
during hepatic surgery [38–41]. Saline-cooled radio-
frequency coagulation has also been used in the kidney
[42–44]. In these cases, the device was used to facilitate
dissection and achieve hemostasis during partial
nephrectomy for renal cell carcinoma.
In summary, we have shown that application of
saline-cooled radiofrequency coagulation is very
effective in achieving hemostasis during hepatic
surgery. Use of the device alone or concurrent with
other techniques results in a very low rate of blood
transfusion or postoperative bile leak.
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